The Discounted Cash Flow (DCF) valuation of Vir Biotechnology Inc (VIR) is (7.97) USD. With the latest stock price at 5.50 USD, the upside of Vir Biotechnology Inc based on DCF is -244.9%.
Based on the latest price of 5.50 USD and our DCF valuation, Vir Biotechnology Inc (VIR) is a sell. selling VIR stocks now will result in a potential gain of 244.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.9% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (30.30) - (3.96) | (7.97) |
| Upside | -650.9% - -172.1% | -244.9% |